Recent News

• 06.01.2026 - Geron to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
• 05.18.2026 - Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 05.12.2026 - First Real-World Evidence Study of RYTELO® (imetelstat) in Lower-risk Myelodysplastic Syndromes (LR-MDS) to be Presented at EHA 2026
• 05.06.2026 - Geron Corporation Reports First Quarter 2026 Financial Results and Recent Business Highlights
• 05.05.2026 - Geron Plans to Present at Upcoming Investor Conferences
• 04.22.2026 - Geron Plans to Announce First Quarter 2026 Financial Results on May 6, 2026
• 04.20.2026 - Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 04.14.2026 - Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
• 04.13.2026 - Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary

Recent Filings

• 05.27.2026 - 8-K Current report
• 05.26.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.26.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.26.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.26.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.26.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.15.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.08.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.06.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 04.14.2026 - 4 Statement of changes in beneficial ownership of securities